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In 1998, the Maltese Government
reactivated its application for full
membership in the EU. Immediately,
the Chamber, given that a plethora of
EU Commission Directives address the
free movement of pharmacists, their
right of establishment and the mutual
recognition of qualifications in
pharmacy and the free movement of
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medicines in the European Economic
Area (EEA), intensified its endeavours
in the field, to be in a “pole”position
to:
• consolidate its European activities,
in the light of the roles played by
the Pharmaceutical Group of the
European Union (PGEU) and
EuroPharm Forum (WHO/Euro) at
The Malta Chamber of Pharmacists, as the National
Pharmaceutical Association, monitors the developments in
local, European and international pharmacy. With the current
national developments, the Chamber’s primary focus is the
impact of EU membership on pharmacists, pharmacy and
medicines.  The Chamber has in fact been studying the impact
of European Union (EU) membership intensively since 1990,
at the time when the then Administration had first formally
applied for full membership in the EU1.
European level, and the Chamber at
European and national levels;
• advise the Government and other
relevant institutions and
Authorities, the members of the
pharmacy profession and the public,
on these matters;
• make recommendations to the
Government and other relevant
institutions and authorities, and the
members of the pharmacy
profession, on the implementation
of the changes to the relevant
legislation and practice;
• prepare the profession and the
country for full membership through
pro-active participation in the
updating of the legislation,
structures and standards pertaining
to pharmacists, pharmacy,
medicines and health;
• empower the active participation of
the Chamber in all the processes
leading to the official negotiations
with the EU on matters concerning
pharmacists, pharmacy, medicines
and health;
• enable Chamber participation in
Brussels, the hub of activity, and in
other EU countries, on affairs
pertaining to pharmacists,
pharmacy, medicines and health;
• engage identified European experts
with the remit to advise the
Chamber Executive Council and to
visit Malta to hold intensive
meetings with the Chamber
Executive Council and workshops/
seminars for members.
The Pharmaceutical Group
of the European Union
After the signature of the Treaty of
Rome, on the 25th March 1957, which
incepted the European Economic
Community (EEC) and the European
Community of Atomic Energy
(Euroatom), few were those
professionals who were quick to realise
the significant implications and
challenges brought about by the “Four
Freedoms” (Freedom of movement of
capital, services, persons and goods).
European pharmacists were amongst
the first to do so, and, in 1957, the
“Groupement”, the Pharmaceutical
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Group of the European Community at
that time, was founded, engrouping the
then six members of the EEC. This has
now evolved into the Pharmaceutical
Group of the European Union (PGEU),
which is the strong lobby group on
pharmaceutical matters based in
Brussels, Belgium. It consists of the
delegations of the National
Pharmaceutical Associations of 15
members (country delegations)
together with a number of observers
mostly from applicant countries for EU
membership and other international
and European Pharmaceutical
institutions.
The pharmaceutical profession,
through the PGEU, maintains relations
with the European Commission, the
European Parliament, the Economic and
Social Council and other European and
international organizations of Health
Care professionals and stakeholders.
Through its founder membership of the
EuroPharm Forum (WHO/Euro) in 1992,
the Chamber has since established a
fruitful collaborative relationship with
the PGEU.
The Pharmacy
Sectorial Directives
The pharmaceutical profession is
mainly regulated by three Directives in
the EU.
Directives 85/432/EEC2 and 85/433/
EEC3 concern the free movement of
pharmacists and the right of
establishment and the mutual
recognition of qualifications in
Pharmacy. Directive 85/434/EEC4
provides for the setting up by the EU
Commission of the Advisory Committee
on Pharmaceutical Training. Moreover,
in May 1994 this latter Committee
issued the document entitled “Report
And Recommendations On
Pharmaceutical Education Undergone At
Higher-Education Institutions”, the
contents of which have been
implemented by several member states,
albeit it is not a directive5.
Article 1 of Directive 85/432/EEC
lays down in paragraph 1.1 that
“Member States shall ensure that
holders of a diploma, certificate or
other University equivalent
qualification in pharmacy which meets
the conditions laid down in Article 2
shall be entitled at least to access to
the activities mentioned in paragraph
1.2 and to pursue such activities,
subject where appropriate to the
requirement of additional professional
experience.”
The activities referred to in this
paragraph are outlined in paragraph 1.2
and include:
• the preparation of the
pharmaceutical form of medicinal
products;
• the manufacture and testing of
medicinal products;
• the testing of medicinal products in
a laboratory;
• the storage preservation and
distribution of medicinal products at
the wholesale stage;
• the preparation, testing, storage
and supply of medicinal products in
pharmacies open to the public;
• the provision of information and
advice on medicinal products.
Article 2 of Directive 85/432/EEC
specifies that training leading to the
formal qualification shall ensure
adequate knowledge:
• of medicines and the substances
used in the manufacture of
medicines;
• of pharmaceutical technology and
the physical, chemical, biological
and microbiological testing of
medicinal products;
• of the metabolism and the effects of
medicinal products and of the
action of toxic substances and of
the use of medicinal products;
• to evaluate scientific data
concerning medicines in order to be
able to supply appropriate
information on the basis of this
knowledge;
• of the legal, ethical and other
requirements associated with the
practice of pharmacy.
Briefly, therefore, any person who
holds a qualification listed in Article 4
of Directive 85/433/EEC, gained by
successful completion of a course of
study complying with Article 2 of
Directive 85/432/EEC, or who meets the
criteria for established rights in Article
6 of Directive 85/433/EEC (Table 1) is
entitled to access in any country of the
EEA to any activity in Article 2 of
Directive  85/433/EEC.
Having taken into consideration all
of the above, the Chamber has made
the following strong recommendations
to the Government.
Mutual Recognition of
Qualifications
The Government must ensure that
Maltese pharmacists who qualified
before the implementation of Directive
85/433/EEC benefit from the
“established rights” provisions of
Directive 85/432/EEC, and that the “cut
off point” should be the date of EU
accession.
Established Rights and
Regulated Areas of Practice -
The Case of Pharmacist
Medical Representatives
With further reference to the
established rights provision in Directive
85/433/EEC, suitable safeguards must
be in place for those pharmacists who
do not comply with Directive 85/432/
EEC nor with the acquired rights
provisions of Directive 85/433/EEC
because they are not practising in a
regulated area of practice.
A case in point is that of
pharmacist medical representatives. It
is vital that medical representation is
immediately designated by the
Government as a regulated area of
practice and that a register of
pharmacist medical representatives is
held by the Pharmacy Board.
Moreover, the necessary structures
for the keeping of registers for existing
specific areas of practice, including the
managing pharmacists of community
pharmacies, pharmacists in hospital
practice, administrative pharmacists,
pharmacists practising in laboratories,
the qualified persons (pharmacists)
designated as responsible pharmacists
of the pharmaceutical activities of
wholesale dealers of medicines, and the
qualified persons in the manufacturing
of medicines, should be set up without
delay.
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In-Service or Pre-Registration
Training - The Case of the
B.Pharm. (Hons.) Class Of 2000
Besides the specifications on the
adequate knowledge required in the
training leading to the formal
qualification mentioned above, Article 2
of Directive 85/432/EEC imposes a
further minimum period of six months
in-service training in a hospital or a
community pharmacy towards the end
of the University course leading to the
qualification in pharmacy6. In 1993, the
Advisory Committee7 laid down the
principles according to which the
monitoring, evaluation and content of
in-service training were to be
determined. The Chamber has studied
the documents of the Advisory
Committee on Pharmaceutical Training
of the EU and other recommendations
of European advisors and has strongly
recommended to the Government and
the University that Malta should
immediately develop the appropriate
supervising and training infrastructure
with appropriate pharmacist mentors in
both hospital and community
pharmacy. However, this is a short term
priority, since there is no provision for
in-service training as yet . Thus,
students in the course at present and
who will graduate this year, are not in
line with Article 2 of Directive 85/432/
EEC3 and on accession, these will not
have freedom of movement unless
provisions in this regard are
immediately taken.
Accession to Activities in
Pharmacy by a National of a
Member State
The Chamber has strongly
recommended that the Licensing
Authority request proof of qualification
(University degree), pre-registration
training, licence to practice (warrant),
proof of actual practice experience, and
certificate of good conduct (civil and
professional conduct and repute,
perhaps reflected in a current licence to
practice and “history” thereof), from
the member state. This is an example of
practice in various member states.
Linguistic Knowledge
It is an ethical requirement that
there is good communication and
understanding between the pharmacist,
indeed any health care professional,
and the patient. Moreover. the Chamber
insists that nationals of Member states
applying for registration in Malta
should be requested to have a good
working knowledge (spoken and
written) of the Maltese Language since
this is the national language of the
Maltese population8.
Advisory Committee on
Pharmaceutical Education
and Training
This Committee comprises, from
each country, three members and three
deputies, representing the competent
authorities, academic pharmacy and the
practising pharmaceutical profession. It
is the Chamber’s strong opinion that
the Government should consult the
Chamber in the appointment of the
member and deputy to represent the
Maltese practising phamaceutical
profession on this Committee.
Specialisation
There is the requirement in the first
directive (85/432/EEC) that the
Commission must make proposals for
specialisation to be undertaken by
pharmacists already registered to
practise pharmacy in the EU. The EU
Advisory Committee on Pharmaceutical
Training has issued documents with
respect to Specialisation in Community
Pharmacy9 but this has not taken the
form of a Directive; the Committee is at
present working on Specialisation in
Hospital Pharmacy and Specialisation in
Clinical or Medical Biology.
In this context, the Chamber has
urged for work to start immediately to
provide for specialisation of Maltese
pharmacists in the various areas of
hospital pharmacy including clinical
pharmacy, community pharmacy,
pharmaceutical industry including
marketing of medicines and wholesale
distribution, laboratories, and
academia. This is so as to safeguard the
position of Maltese pharmacists vis a
vis EEA citizens who already have a
history of specialisation.
The Right of Establishment
The preamble to Directive 85/432/
EEC, states  that “The geographical
distribution of pharmacies and the
monopoly of the supply of medicinal
products continue to be a matter of the
Member States...”.  This national
autonomy is further recognised by
paragraph 7 of Directive 85/433/EEC
which states that: “Whereas, under
their national policies in the sphere of
public health, which seek inter alia to
ensure the satisfactory dispensing of
medicinal products over their entire
Table 1: Established Rights Criteria
Article 6: Directive 85/433/EEC
6.1 Diplomas, certificates and other university or equivalent
qualifications in pharmacy which were awarded to nationals of
Member States by Member States and which do not satisfy all
minimum training requirements laid down in Article 2 of
Directive 85/432 EEC shall be treated as diplomas satisfying
these requirements if:
• they are evidence of training which was completed before the
implementation of the said Directive, or
• they are evidence of training which was completed after but
which was commenced before the implementation of the said
Directives.
and, in each case, if
• they are accompanied by a certificate stating that their
holders have been effectively and lawfully engaged in one of
the activities referred to in Article 1 (2) of Directive 85/432/
EEC in a Member State for at least three consecutive years
during the five years preceding the award of the certificate,
provided that this activity is regulated in that State.
Source:  Council Directive 85/433/EEC. O.J.No.L 253, 24.9.1985. pp 0037-0043.
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addressed such as the definition of a
new pharmacy and the practice by some
States to bar non-nationals from
acquiring and opening a pharmacy. This
report also relaxes the existent criteria
whilst keeping to the principles of
geodemographic organisation. The
report fully liberalises the transfer of
territories, certain Member States
restrict the number of pharmacies that
may be established...”.
The EEC Treaty (Treaty of Rome)
which aimed at the attainment of
absolute freedom of circulation of
merchandise (Article 9-11) of the
labour force (and hence, professionals
including pharmacists) (Article 48-51)
and freedom of establishment of
workers anywhere in the EU (Article 52-
58) freedom of services rendered
(Article 59-66) accepts as lawful any
restrictions imposed by member states
on these matters for reasons of public
order, public security and public health
(Article 48, par. 3, Article 56, par. 1,
Article 68) in which said restrictions
are also included any regulations
concerning the pharmaceutical
profession.
In fact, based on the principle of
“subsidiarity”, which is an important
principle in EU law, all EU countries
have restrictions on the opening of
pharmacies for reasons of public health.
All countries therefore organise the
licensing of pharmacies according to
their needs (Table  2). There are no
grounds whatsoever to believe that this
would be challenged by the Commission
either in the course of negotiation for
entry or on entry itself (PGEU, 2000).
 In this context, the Chamber is
strongly insisting that the legal
provisions that were submitted to the
Hon. Minister of Health in 1999 are
implemented at law, ensuring that
there are no loopholes in the system.
Suitable safeguards must also be
Table 2: State of the Art of Pharmacy Organisation
in the European Union
1. In the majority of member states of the EU, including Denmark, France,
Greece, Italy, Portugal, Spain, Luxembourg, Finland and Austria,
community pharmacy organisation is based on geographical/demographic
considerations; and legislation provides for pharmacist ownership only.
2. The UK, Ireland and Belgium allow non-pharmacists to own a pharmacy,
but the allocation of dispensing contracts under the NHS, in the first two
countries amounts to distribution control, whilst Belgium has distribution
controls. The Dutch government has recently legislated to allow the
ownership of pharmacies by non-pharmacists.
3. In Germany, only pharmacists can own a pharmacy but there are no
distribution regulations.
4. The Swedish system is totally alien to any of the above situations and to
current thinking and practices in the EU (and locally.)
Reference
PGEU, letter from the President, Prof. Dieter Ahlgrimm, to the President of
the Malta Chamber of Pharmacists, April 1996; PGEU, letter from the Vice-
President, Mr. Aidan O’Shea, to the President of the Malta Chamber of
Pharmacists, March 2000 and from Mr. John Ferguson, (UK) April 2000.
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In 1900 a small group of pharmacists met in Valletta and founded the Camera Farmaceutica
di Malta.  Today, in the year 2000, the Malta Chamber of Pharmacists commemorates
this historically significant event for pharmacists by launching its website at
http://www.synapse.net.met/mcp/
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licence. However, the Chamber is urging
the Government to provide the
necessary safeguards, with urgency, in
the incumbent accession negotiations
on free movement of persons and the
right of establishment, so that no non-
Maltese citizen will open a pharmacy in
Malta - and that Parliament should
legislate in favour of planned
distribution of pharmacies, without any
loopholes. This is because under other
circumstances, that is, in the absence
of geodemographic regulation, citizens
of member states and others who are
not allowed to open pharmacies in their
country by their own Government would
be tempted to open in Malta.
The Drafting
of a Pharmacy Act
The changes and challenges faced
by the  Pharmaceutical Profession
during the last century and the
Government’s thrust towards EU
membership in the last decade have
brought about the urgent need to draft
a Pharmacy Profession Act to govern
pharmacists in all areas of practice.
The Chamber made detailed
submissions regarding this issue in
April 2000 (10) at the invitation of the
Director General of Health, since the
Ministry of Health had embarked on the
redrafting of Chapter 31 of the Medical
and Kindred Professions Ordinance. In
the context of EU membership, it is
relevant to highlight the Chamber’s
stance on the following principles:
• that there should be a Pharmacy
Professions Act regulating
pharmacists practising in the
following areas: community and
hospital pharmacy, pharmaceutical
industry including manufacturing,
importation and wholesale
distribution, advertising and
marketing (medical representation)
of medicinal products without
distinction of whether pharmacists
practise in the private or public
sector;
• that in transposing the EU
directives into the main body of the
legislation, there will be no
loopholes with regard to  the
recognition of all pharmacists on
the register on the date of
accession to the EU, so that all may
benefit from the established rights
provision of Directive 85/433/EEC,
even those who do not comply with
the provisions of either Directive
85/432/EEC or Directive 85/433/
EEC;
• that special areas of practice are
immediately designated and that
provisions for the establishment and
keeping of registers by the
Pharmacy Board for different
existent areas of practice are
immediately implemented, i.e., for
the Qualified Person (QP)
pharmacist in pharmaceutical
manufacturing; the Responsible
Pharmacist (RP) in pharmaceutical
wholesale activities, (termed QP by
the DH circular bringing the
requirement into force); pharmacist
medical representatives practicing
pharmaceutical marketing, and of
course, managing pharmacists in
community and hospital practice;
• that the necessary legal provisions
are implemented to ensure that
medical representation is a
regulated area of practice, prior to
the EU accession date;
• that the requirement on wholesale
distribution of medicines should be
transposed into the law to state
that the “Responsible Person” is a
pharmacist;
• that the law should clearly state
that the “qualified person”
responsible for the manufacture of
medicinal products and for the
release of same is a pharmacist. In
this respect the provisions in MKPO
CAP 31; Part X Section 96;
subsection 2 for persons with
“competency in chemistry” should
be appropriately amended;
• that the recommendations
mentioned above on the Licensing
of Pharmacies are transposed into
the law, without loopholes, in the
interest of public health and in the
light of the provisions of the EEC
Rome Treaty and the preamble to
Directive 85/432/EEC to introduce
safeguards on the right of
establishment of pharmacists;
• that the existing Pharmacy Board is
replaced with a Pharmacy Council,
in view of the need for the true self-
governance of the Pharmacy
Profession, based on the principles
of self regulation, autonomy
(financial and administrative), and
transparency of judicial review and
other decisions. The new Pharmacy
Council will have a new
composition which reflects
professional autonomy and self-
regulation, new structures and
resources reflecting  the evolution
of practice and new ethical needs;
the new roles, such as mutual
recognition of qualifications and
specialisation, monitoring of the
undergraduate pharmacy
curriculum, setting up the
provisions and the monitoring of
in-service training, the Pharmacy
Inspectorate and other activities
in the light of EU accession. Thus
the restructuring and review of the
raison d’étre of the Pharmacy
Board is not only of significance
to the Maltese Pharmaceutical
Profession and the public but also
to the European pharmacists who
will be approaching it as the
Authority to evaluate their
eligibility to practice and to
discipline them. The Chamber has
also made strong and consistent
representations with the Minister
of Health to this effect.
Conclusion
Irrespective of the EU accession
exercise which is currently underway,
the changes to legislation governing
Pharmacy and the moving toward the
attainment, in particular, of
structured in-service training and
specialisation have long been felt.
There should also be a joint effort to
attain harmonisation in education and
training. In Europe it is being
advocated, particularly by the
EuroPharm Forum11 and the European
Association of Pharmacy Faculties,
that this may be best achieved
through partnership of Faculties of
Pharmacy and National
Pharmaceutical Associations i.e., by
academics and practitioners. This
objective is fully supported by the
PGEU and EPSA12. It is of course a
moot point that such an initiative is
fully and proactively nurtured by the
Malta Chamber of Pharmacists13. ✱
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The Chamber’s EU Task Force is
headed by Mary Ann Sant Fournier
and includes Mary Anne Ciappara
and David Camilleri. Further
information may be obtained by
visiting the Chamber’s Website at
http://www.synapse.net.mt/mcp/
or by contacting the Chamber’s EU
desk on Tel no 312888, Fax no
343002/or e-mail: mfpb@malta
net.net or spizjar@synapse.net.mt
The Association offers help, support
and advice, and provides useful
information about the Condition and
the gluten-free diet to newly diagnosed
coeliacs. This makes it easier for the
coeliac to overcome the initial shock of
having to change eating habits and to
adapt to a new lifestyle. The
Association also offers on-going
support and advice to members and
their families and provides dietary
guidelines, thus improving the quality
of life for the coeliac.
Get-togethers are held regularly to
give members the opportunity to meet
and also to discuss any problems they
might have. For these activities
members are encouraged to bake
Coelic
Association Malta
gluten-free products which are shared
over coffee. This is also an occasion to
exchange recipes. Speakers are
sometimes invited to give talks to
members on various issues including
medical, dietetic and nutritional
concerns. Occasionally, bread-making
demonstrations are held and social
functions for members and their
families are organised.
The Coeliac Association of Malta is a
member of The Association of European
Coeliac Societies (AOECS) and has
contacts with Coeliac Societies
worldwide. Important information and
research material regarding Coeliac
Disease and the gluten-free diet,
received from Coeliac Societies in other
Coeliac Association Malta is a voluntary organisation for
people with Coeliac Disease or Dermatitis Herpetiformis. It is
a non-profitable support group founded in 1989 by coeliacs
themselves in order to promote the welfare of coeliacs in
Malta. Membership is open to those persons who have been
medically diagnosed with coeliac Condition or Dermatitis
Herpetiformis.
Carole Pace Balzan
Chairperson, Coclic Association Malta
